Haiyang Chen Selected Research

Haiyang Chen Research Topics

Disease

8	Neoplasms (Cancer) 11/2021 - 01/2015
6	Inflammation (Inflammations) 01/2021 - 11/2014
5	Rectal Neoplasms (Rectal Cancer) 01/2022 - 01/2019
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 04/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 11/2016
3	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2013
3	Carcinogenesis 01/2015 - 04/2012
2	Adenocarcinoma of Lung 06/2022 - 12/2020
2	Liver Neoplasms (Liver Cancer) 11/2021 - 01/2015
2	Lung Neoplasms (Lung Cancer) 11/2021 - 10/2017
2	Hyperplasia 01/2021 - 11/2014
2	Infections 01/2021 - 09/2016
2	Nasopharyngeal Carcinoma 01/2019 - 10/2015
2	Breast Neoplasms (Breast Cancer) 01/2015 - 06/2013
2	Cysts 01/2014 - 07/2013
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021
1	Adenocarcinoma 04/2021
1	Microsatellite Instability 04/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Neuroblastoma 01/2021
1	Human Influenza (Influenza) 12/2020
1	Lung Injury 12/2020
1	Pathologic Complete Response 10/2020
1	Colorectal Neoplasms (Colorectal Cancer) 05/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2020
1	Epstein-Barr Virus Infections 01/2020
1	Colitis 01/2020
1	Squamous Cell Carcinoma of Head and Neck 04/2016
1	Disease Progression 04/2016
1	Genomic Instability 01/2016
1	Stomach Neoplasms (Stomach Cancer) 12/2015

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 11/2021 - 02/2010
4	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 04/2015
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
4	Lamin Type B (Lamin B)IBA 01/2016 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2019
2	Tyrosine Kinase InhibitorsIBA 06/2022 - 12/2020
2	ChromatinIBA 01/2022 - 11/2021
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 12/2020
2	Transcription Factors (Transcription Factor)IBA 11/2021 - 01/2010
2	RNA (Ribonucleic Acid)IBA 11/2021 - 04/2015
2	Messenger RNA (mRNA)IBA 01/2021 - 06/2013
2	NF-kappa B (NF-kB)IBA 01/2021 - 01/2010
2	Cadherins (E-Cadherin)IBA 01/2019 - 12/2015
2	LaminsIBA 01/2016 - 07/2013
2	Glucose (Dextrose)FDA LinkGeneric 08/2013 - 01/2013
1	Tyrosine (L-Tyrosine)FDA Link 06/2022
1	ErbB Receptors (EGF Receptor)IBA 06/2022
1	Phosphotransferases (Kinase)IBA 06/2022
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Competitive Endogenous RNAIBA 11/2021
1	Long Noncoding RNAIBA 11/2021
1	Calcibiotic Root Canal SealerIBA 04/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	thiazolyl blueIBA 01/2021
1	1- (diethylaminopropyl)- 4- phenylpiperazineIBA 01/2021
1	mitogen and stress-activated protein kinase 1IBA 01/2021
1	CrizotinibIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	CurcuminIBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	Taurine FDA Link 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 12/2020
1	Biological ProductsIBA 12/2020
1	Hematoxylin (Haematoxylon)IBA 12/2020
1	EndotoxinsIBA 12/2020
1	Anaplastic Lymphoma KinaseIBA 12/2020
1	SeleniumIBA 05/2020
1	Peptides (Polypeptides)IBA 05/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2020
1	Matrix Metalloproteinases (MMPs)IBA 05/2020
1	Small Interfering RNA (siRNA)IBA 05/2020
1	Dextran SulfateIBA 01/2020
1	StathminIBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 04/2018
1	ElacridarIBA 10/2017
1	Docetaxel (Taxotere)FDA Link 10/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2016
1	Gefitinib (Iressa)FDA Link 11/2016
1	Pattern Recognition ReceptorsIBA 09/2016
1	SulfurIBA 04/2016
1	IronIBA 04/2016
1	DNA Transposable Elements (Element, IS)IBA 01/2016
1	HeterochromatinIBA 01/2016
1	TESIBA 01/2016
1	Retroelements (Retrotransposon)IBA 01/2016
1	CateninsIBA 12/2015
1	pladienolide BIBA 04/2015
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2015

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2015
2	Neoadjuvant Therapy 01/2022 - 10/2020
2	Chemoradiotherapy 01/2022 - 01/2019
2	Immunotherapy 11/2021 - 04/2021
2	Drug Therapy (Chemotherapy) 11/2021 - 01/2019
2	Radiotherapy 01/2019 - 10/2015
1	Adjuvant Chemotherapy 10/2020